DK1228708T3 - Mælkeafledt basisk proteinfraktion som middel til formindskelse af höjt blodtryk - Google Patents

Mælkeafledt basisk proteinfraktion som middel til formindskelse af höjt blodtryk

Info

Publication number
DK1228708T3
DK1228708T3 DK02000982T DK02000982T DK1228708T3 DK 1228708 T3 DK1228708 T3 DK 1228708T3 DK 02000982 T DK02000982 T DK 02000982T DK 02000982 T DK02000982 T DK 02000982T DK 1228708 T3 DK1228708 T3 DK 1228708T3
Authority
DK
Denmark
Prior art keywords
milk
blood pressure
high blood
protein fraction
basic protein
Prior art date
Application number
DK02000982T
Other languages
English (en)
Other versions
DK1228708T4 (da
Inventor
Toba Yasuhiro
Takada Yukihiro
Morita Yoshikazu
Abe Takumi
Kawakami Hiroshi
Original Assignee
Snow Brand Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26607795&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1228708(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from JP2001008189A external-priority patent/JP4034516B2/ja
Priority claimed from JP2001008190A external-priority patent/JP4028177B2/ja
Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd
Application granted granted Critical
Publication of DK1228708T3 publication Critical patent/DK1228708T3/da
Publication of DK1228708T4 publication Critical patent/DK1228708T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/24—Organic nitrogen compounds
    • A21D2/26—Proteins
    • A21D2/268—Hydrolysates from proteins
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/24—Organic nitrogen compounds
    • A21D2/26—Proteins
    • A21D2/261—Animal proteins
    • A21D2/263—Animal proteins from dairy products
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A23L2/66—Proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK02000982T 2001-01-16 2002-01-16 Mælkeafledt basisk proteinfraktion som middel til formindskelse af höjt blodtryk DK1228708T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001008189A JP4034516B2 (ja) 2001-01-16 2001-01-16 脂質代謝改善剤
JP2001008190A JP4028177B2 (ja) 2001-01-16 2001-01-16 血圧降下剤

Publications (2)

Publication Number Publication Date
DK1228708T3 true DK1228708T3 (da) 2004-07-05
DK1228708T4 DK1228708T4 (da) 2008-01-07

Family

ID=26607795

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02000982T DK1228708T4 (da) 2001-01-16 2002-01-16 Mælkeafledt basisk proteinfraktion som middel til formindskelse af höjt blodtryk

Country Status (7)

Country Link
US (2) US20030040475A1 (da)
EP (1) EP1228708B2 (da)
AT (1) ATE261669T1 (da)
DE (1) DE60200256T3 (da)
DK (1) DK1228708T4 (da)
ES (1) ES2215940T5 (da)
PT (1) PT1228708E (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3028411B2 (ja) 1997-09-26 2000-04-04 カルピス株式会社 トリペプチド高生産性ラクトバチルス・ヘルベチカス乳酸菌
EP1142481B2 (en) * 1999-01-11 2009-09-02 Calpis Co., Ltd. Process for producing fermented milk containing angiotensin converting enzyme inhibitory peptide and process for producing milk serum
JP4633876B2 (ja) 1999-11-11 2011-02-16 カルピス株式会社 トリペプチドの製造方法
JP2002193817A (ja) * 2000-12-28 2002-07-10 Calpis Co Ltd 整腸剤
JP3668241B2 (ja) * 2001-12-28 2005-07-06 株式会社Ｎｒｌファーマ 脂質代謝改善用組成物
WO2005074968A2 (en) * 2004-02-10 2005-08-18 Universiteit Maastricht Medical use of basic peptides
EP1685764A1 (en) 2005-01-27 2006-08-02 Globus Egg Sciences B.V. Anti-hypertensive functional food products
TW200605902A (en) * 2004-08-05 2006-02-16 Maxluck Biotechnology Corp Composition for lowering blood lipid
JP4834671B2 (ja) * 2005-09-29 2011-12-14 株式会社マルハニチロ水産 成人病の予防及び治療に有効な組成物
KR20090119785A (ko) * 2007-03-12 2009-11-19 유키지루시 뉴교 가부시키가이샤 성장 호르몬 분비 촉진제
WO2009034325A1 (en) * 2007-09-14 2009-03-19 Cammedica Limited Isoflavone formulation
FI122252B (fi) * 2008-01-04 2011-10-31 Valio Oy Koostumus maksa-aineenvaihdunnan parantamiseksi ja diagnostinen menetelmä
US20110165138A1 (en) * 2008-06-26 2011-07-07 Healthlinx Limited Protocols for treating and preventing obesity and complications arising therefrom
CN102791849B (zh) * 2010-03-10 2014-11-12 株式会社钟化 含乳酸菌制剂
CA2823505A1 (en) * 2011-01-26 2012-08-02 Megmilk Snow Brand Co., Ltd. Agent for improving peripheral sensitivity of skin
IL282198B2 (en) 2011-09-11 2025-11-01 Minovia Therapeutics Ltd Compositions of functional mitochondria and uses thereof
JP6395350B2 (ja) * 2013-03-28 2018-09-26 雪印メグミルク株式会社 筋萎縮防止剤
JP6309202B2 (ja) * 2013-03-28 2018-04-11 雪印メグミルク株式会社 タンパク質組成物およびその製造方法
WO2020021539A1 (en) 2018-07-22 2020-01-30 Minovia Therapeutics Ltd. Mitochondrial augmentation therapy of muscle diseases
US12502408B2 (en) 2018-07-22 2025-12-23 Minovia Therapeutics Ltd. Mitochondrial augmentation therapy for primary mitochondrial diseases
US12329781B2 (en) 2018-07-22 2025-06-17 Minovia Therapeutics Ltd. Mitochondrial augmentation therapy of renal diseases
JP7524157B2 (ja) 2018-07-22 2024-07-29 ミノヴィア セラピューティクス リミテッド 脳疾患のミトコンドリア増強療法
EP3823644A4 (en) 2018-07-22 2022-06-08 Minovia Therapeutics Ltd. MITOCHONDRIAL AUGMENTATION THERAPY OF PANCREATIC DISEASES
WO2020021535A1 (en) 2018-07-22 2020-01-30 Minovia Therapeutics Ltd. Mitochondrial augmentation therapy of ocular diseases
MX2022012157A (es) 2020-03-31 2023-02-15 Minovia Therapeutics Ltd Celulas geneticamente modificadas enriquecidas con mitocondrias y usos de estas.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE458818B (sv) † 1987-11-27 1989-05-16 Svenska Mejeriernas Riksforeni Foerfarande foer utvinning av rena fraktioner av laktoperoxidas och laktoferrin ur mjoelkserum
DK0545946T3 (da) * 1990-07-13 2005-05-23 Gropep Ltd Vækstfremmende middel
AUPN271295A0 (en) * 1995-05-02 1995-05-25 Gropep Pty Ltd Method of treatment
JP2944008B2 (ja) * 1990-09-20 1999-08-30 森永乳業株式会社 非経口脂質代謝改善剤
JP2974604B2 (ja) † 1996-01-23 1999-11-10 雪印乳業株式会社 塩基性タンパク質組成物、塩基性ペプチド組成物及びその利用
JP4082782B2 (ja) * 1998-04-30 2008-04-30 雪印乳業株式会社 歯周病予防及び改善剤
US6649590B2 (en) * 2000-06-09 2003-11-18 Snow Brand Milk Products Co., Ltd. Method of producing fractions containing a high concentration of milk basic cystatin and decomposition products thereof

Also Published As

Publication number Publication date
DK1228708T4 (da) 2008-01-07
ES2215940T5 (es) 2008-03-16
ATE261669T1 (de) 2004-04-15
US20030040475A1 (en) 2003-02-27
EP1228708A2 (en) 2002-08-07
US6929806B2 (en) 2005-08-16
EP1228708B1 (en) 2004-03-17
ES2215940T3 (es) 2004-10-16
EP1228708B2 (en) 2007-08-22
DE60200256T3 (de) 2008-04-03
DE60200256T2 (de) 2005-03-03
DE60200256D1 (de) 2004-04-22
PT1228708E (pt) 2004-05-31
EP1228708A3 (en) 2002-08-14
US20040167078A1 (en) 2004-08-26

Similar Documents

Publication Publication Date Title
DK1228708T4 (da) Mælkeafledt basisk proteinfraktion som middel til formindskelse af höjt blodtryk
CY1110547T1 (el) Συμπυκνωμενα πρωτεϊνικα σκευασματα μειωμενου ιξωδους
UY27940A1 (es) Formulacion de anticuerpos humanos para el tratamiento de trastornos asociados con tnf-a
DE602005026031D1 (de) Kristalline formen von (-)-(1r,2r)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenolhydrochlorid zur verwendung als aktivstoff in pharmazeutischen zubereitungen
UY27586A1 (es) Cis- imidaxolinas
WO2007011874A3 (en) Formulation and method for administration of ophthalmologically active agents
DK1492761T3 (da) Aminosyrer med affinitet til alpha-2-delta-proteinet
NO20062508L (no) Administrering av levodopa og karbidopa
ATE488233T1 (de) Verminderung der nebenwirkungen bei der oxybutynin-therapie
EP2186824A3 (en) Chronic treatment regimen using glucagon-like insulinotropic peptides
AR047841A1 (es) Metodos y composiciones para el tratamiento de transtornos inmunoinflamatorios
WO2005021022A3 (en) Stable formulations of peptides
WO2003016335A3 (en) Irreversible cysteine protease inhibitors of legumain
WO2004006756A3 (en) THERAPIES FOR RENAL FAILURE USING INTERFERON-β
EA200800337A1 (ru) Композиция и способ введения офтальмологически активных средств
BRPI0516577A (pt) agentes terapêuticos com toxicidade diminuìda
EP1466602A4 (en) ORGAN FIBROSIS INHIBITORS
WO2006077427A3 (en) Antiviral drug combinations
NO20054440L (no) Flytende formuleringer av tumornekrosefaktorbindende proteiner
DK1553985T3 (da) Biphenyler som billeddannelsesmiddel i forbindelse med Alzheimers sygdom
BR0213536A (pt) Formulações de xarope de ribavirina
ITRM20010438A0 (it) Preparato oftalmico a base di n-acetilcisteina per il trattamento della sindrome dell'occhio secco.
IS8308A (is) Amínósýrur með sækni fyrir a2o prótíninu
NO20034524D0 (no) 5-leddete heterocykler, fremstilling og anvendelse derav som MAO inhibitorer og lipidperoksidasjonsinhibitorer, fremstilling derav oganvendelse derav sommedikamenter
DK1418905T3 (da) Terapeutisk middel til depletering af en uönsket proteinpopulation fra plasma